The Lancet Haematology in conversation with

Lan-Lan Smith, Editor-in-Chief, Emma Cookson, Deputy Editor, and Daniela Marín, Senior Editor at The Lancet Haematology, in conversation with the journal’s authors, explore their latest research and its impact on people’s health, healthcare, and health policy.A monthly audio companion to the journal, this podcast covers a broad range of topics, from racial and ethnic disparities in leukaemia survival outcomes to resuscitation with blood products compared with saline, the link between mental health and lymphoma to haemolytic disease in newborns, and more.

The Lancet Haematology in conversation with is a health podcast hosted by Unknown Host, with 55 episodes on record and a Required Pod Score of 80. PitchCentric scores this show on Booking Probability, Listen Score, and live audience signals refreshed every 24 hours.

Unknown Host hosts The Lancet Haematology in conversation with, a health show with 55 episodes published.

Our AI reads these to draft pitches. Use them as grounding for a pitch that cites a real guest and a specific topic.

• 

  Episode #6

  Adverse event reporting in haematological malignancies with the authors of our Adverse Events Series

  Aug 27, 202636 min

  Blood cancer treatments are advancing fast — but so are their side effects. Hear from the authors of The Lancet Haematology's Adverse Event reporting series on better trial design, patient-centric care, and what part 2 (2026) reveals about long-term toxicity, survivorship, regulation, and digital health tools. Click here to visit the series hub on thelancet.com : https://www.thelancet.com/series-do/adverse-events-in-haematology-oncology The Lancet Haematology in conversation with... is part of the Lancet Group podcast offering. Editorial team: editor-in-chief Lan-Lan Smith, deputy editor Emma Cookson, and senior editor Daniela Marin Podcast editing: Matteo Simonetti Visit https://www.thelancet.com/multimedia to learn more about our multimedia offering. Find the best science for better lives at www.thelancet.com Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv

  ListenShow Notes
• 

  Episode #5

  Bethany Samuelson Bannow and Maureen Achebe on classical haematological disease in women

  Aug 6, 202624 min

  Dr Lan-Lan Smith joined the lead author of our latest Commission Dr Bethany Samuelson Bannow and author Dr Maureen Achebe to discuss classical haematological disease in women with Dr Julia Sandrin Gauer from the Intenational Society on Thrombosis and Haemostasis. The podcast was recorded and produced by the ISTH to coincide with the launch of the Commission at the ISTH congress in Paris in July 2026. Click here to read the commission on thelancet.com: https://www.thelancet.com/commissions-do/women-bleeding-thrombosis The Lancet Haematology in conversation with... is part of the Lancet Group podcast offering. Editorial team: editor-in-chief Lan-Lan Smith, deputy editor Emma Cookson, and senior editor Daniela Marin Podcast editing: Matteo Simonetti Visit https://www.thelancet.com/multimedia to learn more about our multimedia offering. Find the best science for better lives at www.thelancet.com Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv

  ListenShow Notes
• 

  Episode #4

  Fabio Efficace and Alice Di Rocco on patient-reported outcomes following CAR T-cell therapy

  Jul 3, 202616 minS0

  <p>Most previous patient-reported outcome results for CAR T-cell therapy have come from clinical trials testing these treatments, but information on how patients experience this treatment in real-world settings is scarce. </p> <p>Dr Fabio Efficace and Dr Alice Di Rocco discuss their recent prospective study to measure real-world patient-reported symtomatic adverse events in those receiving CAR T-cell therapy for aggressive B-cell lymphomas, and how these outcomes match those reported by the physicans treating the patients. They discuss some of the rich and varied findings that they uncovered from their study.</p> <p>Click here to read the full article:<...

  ListenShow Notes
• 

  Episode #3

  Carmelo Gurnari on the development of recommendations from the EBMT Practice Harmonisation and Guidelines Committee

  Jun 4, 202617 minS0

  <p>Dr Carmelo Gurnari joins us to discuss the development of recommendations from the EBMT Practice Harmonisation and Guidelines Committee on diagnosis, prevention, treatment, and donor management of donor cell-derived haematological neoplasms after HCT</p> <p>click here to read the full article:</p> <p>https://www.thelancet.com/journals/lanhae/article/PIIS2352-3026(26)00046-3/fulltext</p> <p>The Lancet Haematology in conversation with...  is part of the Lancet Group podcast offering. </p> <p>Editorial team: editor-in-chief Lan-Lan Smith, deputy editor Emma Cookson, and senior editor Daniela Marin</p> <p>Podcast editing: Matteo Simonetti</p> <p>Visit https://www.thelancet.com/m...

  ListenShow Notes
• 

  Episode #2

  Penelope Stein on acute prophyria

  Apr 28, 202616 minS0

  <p>Dr Penelope Stein joins us to discuss the development of new international guidelines for the diagnosis, management, and treatment of the rare, genetically-linked condition, acute prophyria.</p> <p>Click here to read the full article: https://www.thelancet.com/journals/lanhae/article/PIIS2352-3026(26)00044-X/fulltext</p> <p>The Lancet Haematology in conversation with...  is part of the Lancet Group podcast offering. </p> <p>Editorial team: editor-in-chief Lan-Lan Smith, deputy editor Emma Cookson, and senior editor Daniela Marin</p> <p>Podcast editing: Matteo Simonetti</p> <p>Visit https://www.thelancet.com/multimedia to learn more about our multimedia offering. </p> <p>...

  ListenShow Notes

Recent guests on The Lancet Haematology in conversation with. Study who booked and why before you pitch.

Based on semantic analysis of episode topics and host coverage, this show is a strong guest fit for executives in:

Industry fit is computed by PitchCentric using vector embeddings of the show's episode catalog.